These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
667 related articles for article (PubMed ID: 31511383)
1. The Education of NK Cells Determines Their Responsiveness to Autologous HIV-Infected CD4 T Cells. Kiani Z; Dupuy FP; Bruneau J; Lebouché B; Retière C; Geraghty DE; Bernard NF J Virol; 2019 Dec; 93(23):. PubMed ID: 31511383 [TBL] [Abstract][Full Text] [Related]
2. The differential impact of natural killer (NK) cell education via KIR2DL3 and KIR3DL1 on CCL4 secretion in the context of in-vitro HIV infection. Lisovsky I; Isitman G; Tremblay-McLean A; Song R; DaFonseca S; Lebouchẻ B; Routy JP; Bruneau J; Bernard NF Clin Exp Immunol; 2016 Dec; 186(3):336-346. PubMed ID: 27506421 [TBL] [Abstract][Full Text] [Related]
3. A Higher Frequency of NKG2A+ than of NKG2A- NK Cells Responds to Autologous HIV-Infected CD4 Cells irrespective of Whether or Not They Coexpress KIR3DL1. Lisovsky I; Isitman G; Song R; DaFonseca S; Tremblay-McLean A; Lebouché B; Routy JP; Bruneau J; Bernard NF J Virol; 2015 Oct; 89(19):9909-19. PubMed ID: 26202228 [TBL] [Abstract][Full Text] [Related]
4. HIV protective KIR3DL1/S1-HLA-B genotypes influence NK cell-mediated inhibition of HIV replication in autologous CD4 targets. Song R; Lisovsky I; Lebouché B; Routy JP; Bruneau J; Bernard NF PLoS Pathog; 2014 Jan; 10(1):e1003867. PubMed ID: 24453969 [TBL] [Abstract][Full Text] [Related]
5. Expression Profiles of Ligands for Activating Natural Killer Cell Receptors on HIV Infected and Uninfected CD4⁺ T Cells. Tremblay-McLean A; Bruneau J; Lebouché B; Lisovsky I; Song R; Bernard NF Viruses; 2017 Oct; 9(10):. PubMed ID: 29023371 [TBL] [Abstract][Full Text] [Related]
6. Natural killer (NK) cell receptor-HLA ligand genotype combinations associated with protection from HIV infection: investigation of how protective genotypes influence anti HIV NK cell functions. Bernard NF AIDS Res Ther; 2017 Sep; 14(1):38. PubMed ID: 28893287 [TBL] [Abstract][Full Text] [Related]
7. Functional advantage of educated KIR2DL1(+) natural killer cells for anti-HIV-1 antibody-dependent activation. Gooneratne SL; Center RJ; Kent SJ; Parsons MS Clin Exp Immunol; 2016 Apr; 184(1):101-9. PubMed ID: 26647083 [TBL] [Abstract][Full Text] [Related]
8. HIV infection abrogates the functional advantage of natural killer cells educated through KIR3DL1/HLA-Bw4 interactions to mediate anti-HIV antibody-dependent cellular cytotoxicity. Parsons MS; Wren L; Isitman G; Navis M; Stratov I; Bernard NF; Kent SJ J Virol; 2012 Apr; 86(8):4488-95. PubMed ID: 22345455 [TBL] [Abstract][Full Text] [Related]
9. HLA-F on Autologous HIV-Infected Cells Activates Primary NK Cells Expressing the Activating Killer Immunoglobulin-Like Receptor KIR3DS1. Kiani Z; Bruneau J; Geraghty DE; Bernard NF J Virol; 2019 Sep; 93(18):. PubMed ID: 31270222 [TBL] [Abstract][Full Text] [Related]
10. Increased frequency and function of KIR2DL1-3⁺ NK cells in primary HIV-1 infection are determined by HLA-C group haplotypes. Körner C; Granoff ME; Amero MA; Sirignano MN; Vaidya SA; Jost S; Allen TM; Rosenberg ES; Altfeld M Eur J Immunol; 2014 Oct; 44(10):2938-48. PubMed ID: 25043727 [TBL] [Abstract][Full Text] [Related]
11. Host KIR/HLA-C Genotypes Determine HIV-Mediated Changes of the NK Cell Repertoire and Are Associated With Vpu Sequence Variations Impacting Downmodulation of HLA-C. Vollmers S; Lobermeyer A; Niehrs A; Fittje P; Indenbirken D; Nakel J; Virdi S; Brias S; Trenkner T; Sauer G; Peine S; Behrens GMN; Lehmann C; Meurer A; Pauli R; Postel N; Roider J; Scholten S; Spinner CD; Stephan C; Wolf E; Wyen C; Richert L; Norman PJ; Sauter J; Schmidt AH; Hoelzemer A; Altfeld M; Körner C Front Immunol; 2022; 13():922252. PubMed ID: 35911762 [TBL] [Abstract][Full Text] [Related]
12. Influence of HLA-C environment on the spontaneous clearance of hepatitis C in European HIV-HCV co-infected individuals. Legrand N; David G; Rodallec A; Gaultier A; Salmon D; Cesbron A; Wittkop L; Raffi F; Gendzekhadze K; Retière C; Allavena C; Gagne K Clin Exp Immunol; 2021 Apr; 204(1):107-124. PubMed ID: 33314121 [TBL] [Abstract][Full Text] [Related]
13. Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation. David G; Djaoud Z; Willem C; Legrand N; Rettman P; Gagne K; Cesbron A; Retière C J Immunol; 2013 Nov; 191(9):4778-88. PubMed ID: 24078689 [TBL] [Abstract][Full Text] [Related]
14. Differential contribution of education through KIR2DL1, KIR2DL3, and KIR3DL1 to antibody-dependent (AD) NK cell activation and ADCC. Lisovsky I; Kant S; Tremblay-McLean A; Isitman G; Kiani Z; Dupuy FP; Gilbert L; Bruneau J; Shoukry NH; Lebouché B; Bernard NF J Leukoc Biol; 2019 Mar; 105(3):551-563. PubMed ID: 30698860 [TBL] [Abstract][Full Text] [Related]
15. NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts. Isitman G; Tremblay-McLean A; Lisovsky I; Bruneau J; Lebouché B; Routy JP; Bernard NF PLoS One; 2016; 11(10):e0164517. PubMed ID: 27732638 [TBL] [Abstract][Full Text] [Related]
16. Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1*h/*y and HLA-B*57. Kamya P; Boulet S; Tsoukas CM; Routy JP; Thomas R; Côté P; Boulassel MR; Baril JG; Kovacs C; Migueles SA; Connors M; Suscovich TJ; Brander C; Tremblay CL; Bernard N; J Virol; 2011 Jun; 85(12):5949-60. PubMed ID: 21471235 [TBL] [Abstract][Full Text] [Related]
17. The role genes encoding of killer cell immunoglobulin-like receptors (KIRs) and their ligands in susceptibility to and progression of HIV infection. Błachowicz O; Zwolińska K Postepy Hig Med Dosw (Online); 2016 Dec; 70(0):1409-1423. PubMed ID: 28100849 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory KIR/HLA incompatibility between sexual partners confers protection against HIV-1 transmission. Jennes W; Verheyden S; Mertens JW; Camara M; Seydi M; Dieye TN; Mboup S; Demanet C; Kestens L Blood; 2013 Feb; 121(7):1157-64. PubMed ID: 23243280 [TBL] [Abstract][Full Text] [Related]